1 citations
,
September 2022 in “Journal of The American Academy of Dermatology” In this analysis of two trials, baricitinib showed eyebrow and eyelash regrowth in severe alopecia areata patients with greater than 20% scalp hair loss at Week 36, compared to placebo.
July 2022 in “Journal of Investigative Dermatology” This study suggests that using a non-medicated, hypo-allergenic scalp clarifying shampoo may improve hair volume and reduce shedding in women with lichen planopilaris and female pattern hair loss.
April 2018 in “Journal of Investigative Dermatology” In this study, topical tofacitinib significantly promoted hair regrowth in mice, outpacing both minoxidil and controls over 21 days, with findings suggesting increased VEGF levels and decreased inflammation as possible mechanisms.
May 2011 in “Harper's Textbook of Pediatric Dermatology” This chapter discusses alopecia areata and reports no new findings; it reviews the efficacy of current treatments like corticosteroids, topical sensitizers, and minoxidil, noting the lack of a cure or preventive measures.
2 citations
,
February 2009 in “Journal of Evidence-Based Medicine” This review of randomized controlled trials for alopecia areata treatments found that none were significantly better than placebo in promoting long-term hair growth, with most trials being small and poorly reported.
80 citations
,
October 1983 in “BMJ” This study found that 1% topical minoxidil induced significant hair regrowth in patients with alopecia areata, though it was less effective for those with extensive hair loss such as alopecia totalis and universalis.
31 citations
,
January 1981 This abstract reviews the causes and prognosis of alopecia areata but reports no new clinical findings.